The effect of platelet lysate supplementation of a dextran-based hydrogel on cartilage formation

Biomaterials

Volumn 33, Issue 14, 2012, Pages 3651-3661

  Moreira Teixeira, Liliana S ^a   Leijten, Jeroen C H ^a   Wennink, Jos W H ^a   Chatterjea, Anindita G ^a   Feijen, Jan ^a   van Blitterswijk, Clemens A ^a   Dijkstra, Pieter J ^a   Karperien, Marcel ^a  

^a UNIVERSITY OF TWENTE   (Netherlands)

Author keywords

Cartilage tissue engineering; Cell proliferation; Chemotaxis; Hydrogel; In situ crosslinking; Platelet lysate

Indexed keywords

ANTI-INFLAMMATORIES; BIOLOGICAL SIGNALS; CARTILAGE FORMATION; CARTILAGE REPAIR; CARTILAGE TISSUE ENGINEERING; CARTILAGE TISSUES; CELL MIGRATION; CELL-FREE; CHEMOTAXIS; CHONDROGENIC DIFFERENTIATION; CLINICAL SETTINGS; COVALENT ATTACHMENT; CYTOKINES; DEXTRAN-BASED HYDROGELS; ENZYMATIC CROSSLINKING; GEL FORMATION; GROWTH FACTOR; IN SITU CROSSLINKING; IN-SITU; INJECTABLE HYDROGELS; MESENCHYMAL STROMAL CELLS;

ADHESION; BIOCHEMISTRY; BIOMECHANICS; CARTILAGE; CELL PROLIFERATION; COAGULATION; DEXTRAN; GELATION; GELS; MECHANICAL PROPERTIES; PEPTIDES; PLATELETS; TISSUE; TISSUE ENGINEERING;

HYDROGELS;

BONE MORPHOGENETIC PROTEIN 6; COLLAGEN TYPE 2; DEXTRAN DERIVATIVE; DEXTRAN TYRAMINE; OSTEOCALCIN; TRANSFORMING GROWTH FACTOR BETA3; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE CELL; CELL ADHESION; CELL DIFFERENTIATION; CELL INFILTRATION; CELL LYSATE; CELL SPREADING; CHONDROGENESIS; COCULTURE; CONTROLLED STUDY; COVALENT BOND; CROSS LINKING; HUMAN; HUMAN CELL; HYDROGEL; MESENCHYMAL STEM CELL; OSTEOBLAST; PLATELET LYSATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VISCOELASTICITY;

BIOCOMPATIBLE MATERIALS; BIOMECHANICS; BLOOD PLATELETS; CARTILAGE; CELL ADHESION; CELL DIFFERENTIATION; CELL MOVEMENT; CHONDROCYTES; CHONDROGENESIS; COCULTURE TECHNIQUES; DEXTRANS; GROWTH SUBSTANCES; HUMANS; HYDROGELS; MATERIALS TESTING; MESENCHYMAL STROMAL CELLS; MICROSCOPY, ELECTRON, SCANNING; OSTEOARTHRITIS; TISSUE ENGINEERING; TYRAMINE;

EID: 84857781639     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2012.01.051     Document Type: Article

References (37)

1. Lu H.H., Vo J.M., Chin H.S., Lin J., Cozin M., Tsay R., et al. Controlled delivery of platelet-rich plasma-derived growth factors for bone formation. J Biomed Mater Res A 2008, 86:1128-1136.
2. Zimmermann R., Jakubietz R., Jakubietz M., Strasser E., Schlegel A., Wiltfang J., et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 2001, 41:1217-1224.
3. Saito M., Takahashi K.A., Arai Y., Inoue A., Sakao K., Tonomura H., et al. Intraarticular administration of platelet-rich plasma with biodegradable gelatin hydrogel microspheres prevents osteoarthritis progression in the rabbit knee. Clin Exp Rheumatol 2009, 27:201-207.
4. Sampson S., Reed M., Silvers H., Meng M., Mandelbaum B. Injection of platelet-rich plasma in patients with primary and secondary knee osteoarthritis: a pilot study. Am J Phys Med Rehabil 2010, 89:961-969.
5. Ahmed T.A., Giulivi A., Griffith M., Hincke M. Fibrin glues in combination with mesenchymal stem cells to develop a tissue-engineered cartilage substitute. Tissue Eng Part A 2011, 17:323-335.
6. Calich A.L., Domiciano D.S., Fuller R. Osteoarthritis: can anti-cytokine therapy play a role in treatment?. Clin Rheumatol 2010, 29:451-455.
7. Iliopoulos D., Gkretsi V., Tsezou A. Proteomics of osteoarthritic chondrocytes and cartilage. Expert Rev Proteomics 2010, 7:749-760.
8. Mulhall K.J., Ghomrawi H.M., Scully S., Callaghan J.J., Saleh K.J. Current etiologies and modes of failure in total knee arthroplasty revision. Clin Orthop Relat Res 2006, 446:45-50.
9. Moreira Teixeira L.S., Georgi N., Leijten J.C.H., Wu L., Karperien M. Cartilage tissue engineering. Endocr Dev 2011, 21:102-115.
10. Mehta S., Watson J.T. Platelet rich concentrate: basic science and current clinical applications. J Orthop Trauma 2008, 22:432-438.
11. Jin R., Hiemstra C., Zhong Z., Feijen J. Enzyme-mediated fast in situ formation of hydrogels from dextran-tyramine conjugates. Biomaterials 2007, 28:2791-2800.
12. Jin R., Moreira Teixeira L.S., Dijkstra P.J., Zhong Z., van Blitterswijk C.A., Karperien M., et al. Enzymatically crosslinked dextran-tyramine hydrogels as injectable scaffolds for cartilage tissue engineering. Tissue Eng Part A 2010, 16:2429-2440.
13. Jin R., Moreira Teixeira L.S., Dijkstra P.J., van Blitterswijk C.A., Karperien M., Feijen J. Chondrogenesis in injectable enzymatically crosslinked heparin/dextran hydrogels. J Control Release 2011, 152(1):186-195.
14. Jin R., Teixeira L.S., Dijkstra P.J., van Blitterswijk C.A., Karperien M., Feijen J. Enzymatically-crosslinked injectable hydrogels based on biomimetic dextran-hyaluronic acid conjugates for cartilage tissue engineering. Biomaterials 2010, 31:3103-3113.
15. Hildner F., Albrecht C., Gabriel C., Redl H., van Griensven M. State of the art and future perspectives of articular cartilage regeneration: a focus on adipose-derived stem cells and platelet-derived products. J Tissue Eng Regen Med 2011, 5:e36-e51.
16. Bian L., Zhai D.Y., Mauck R.L., Burdick J.A. Coculture of human mesenchymal stem cells and articular chondrocytes reduces hypertrophy and enhances functional properties of engineered cartilage. Tissue Eng Part A 2011, 17:1137-1145.
17. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
18. Acharya C., Adesida A., Zajac P., Mumme M., Riesle J., Martin I., et al. Enhanced chondrocyte proliferation and mesenchymal stromal cells chondrogenesis in coculture pellets mediate improved cartilage formation. J Cell Physiol 2012, 227:88-97.
19. Wu L., Leijten J.C., Georgi N., Post J.N., van Blitterswijk C.A., Karperien M. Trophic effects of mesenchymal stem cells increase chondrocyte proliferation and matrix formation. Tissue Eng Part A 2011, 17(9-10):1425-1436.
20. De Boer J., Jukes J.M., Both S.K., Leusink A., Sterk L.M.T., Van Blitterswijk C.A. Endochondral bone tissue engineering using embryonic stem cells. P Natl Acad Sci USA 2008, 105:6840-6845.
21. Jin R., Moreira Teixeira L.S., Dijkstra P.J., Karperien M., van Blitterswijk C.A., Zhong Z.Y., et al. Injectable chitosan-based hydrogels for cartilage tissue engineering. Biomaterials 2009, 30:2544-2551.
22. Hendriks J., Riesle J., van Blitterswijk C.A. Co-culture in cartilage tissue engineering. J Tissue Eng Regen M 2007, 1:170-178.
23. Hendriks J.A.A., Miclea R.L., Schotel R., de Bruijn E., Moroni L., Karperien M., et al. Primary chondrocytes enhance cartilage tissue formation upon co-culture with a range of cell types. Soft Matter 2010, 6:5080-5088.
24. Chevallier N., Anagnostou F., Zilber S., Bodivit G., Maurin S., Barrault A., et al. Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. Biomaterials 2010, 31:270-278.
25. Crespo-Diaz R., Behfar A., Butler G.W., Padley D.J., Sarr M.G., Bartunek J., et al. Platelet lysate consisting of a natural repair proteome supports human mesenchymal stem cell proliferation and chromosomal stability. Cell Transplant 2010, 20(6):797-811.
26. Sanchez A.R., Sheridan P.J., Kupp L.I. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003, 18:93-103.
27. Ahmed T.A., Dare E.V., Hincke M. Fibrin: a Versatile scaffold for tissue engineering applications. Tissue Eng Part B Rev 2008, 14(2):199-215.
28. Ahmed T.A., Griffith M., Hincke M. Characterization and inhibition of fibrin hydrogel-degrading enzymes during development of tissue engineering scaffolds. Tissue Eng 2007, 13:1469-1477.
29. Pettersson S., Wettero J., Tengvall P., Kratz G. Human articular chondrocytes on macroporous gelatin microcarriers form structurally stable constructs with blood-derived biological glues in vitro. J Tissue Eng Regen Med 2009, 3:450-460.
30. Ts'ao C.H., Krajewski D.V. Effect of dextran on platelet activation by polymerizing fibrin. Am J Pathol 1982, 106:1-7.
31. Koelling S., Kruegel J., Irmer M., Path J.R., Sadowski B., Miro X., et al. Migratory chondrogenic progenitor cells from repair tissue during the later stages of human osteoarthritis. Cell Stem Cell. 2009, 4:324-335.
32. Greiling D., Clark R.A. Fibronectin provides a conduit for fibroblast transmigration from collagenous stroma into fibrin clot provisional matrix. J Cell Sci 1997, 110(Pt 7):861-870.
33. Xu J., Clark R.A. Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol 1996, 132:239-249.
34. Akeda K., An H.S., Okuma M., Attawia M., Miyamoto K., Thonar E.J., et al. Platelet-rich plasma stimulates porcine articular chondrocyte proliferation and matrix biosynthesis. Osteoarthritis Cartilage 2006, 14:1272-1280.
35. Roussy Y., Bertrand Duchesne M.P., Gagnon G. Activation of human platelet-rich plasmas: effect on growth factors release, cell division and in vivo bone formation. Clin Oral Implants Res 2007, 18:639-648.
36. Moreira Teixeira L.S., Bijl S., Pully V.V., Otto C., Jin R., Karperien M., et al. Self-Attaching and cell-attracting in-situ forming dextran-tyramine conjugates hydrogels for Arthroscopic cartilage repair. Biomaterials 2012, http://dx.doi.org/10.1016/j.biomaterials.2012.01.001.
37. Woodell-May J., Matuska A., Oyster M., Welch Z., O'Shaughnessey K., Hoeppner J. Autologous protein solution inhibits MMP-13 production by IL-1beta and TNFalpha-stimulated human articular chondrocytes. J Orthop Res 2011, 29(9):1320-1326.